Peptaris

Artificial Intelligence

Overview

Peptaris is building an AI-powered platform to design peptides with the properties they need to become viable medicines.

Funding and backers

Total raised
$4M
1 round on record
Latest round
$4M
Convertible Note · Jun 2026 · 5 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 1 Raised a round Convertible Note $4M · SEC Form D 2025 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Jun 2026 $4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Peptaris, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Francis HerbertExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
At IDN, our vision is to become the consumer tech platform that empowers Indonesia.
NOHO pairs you with expert doctors who design peptide protocols around your labs, goals, and response, supported by concierge care. Begin…
Menten AIFounded 2018 · 11-50 employees
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Smith RoboticsVenture round · 3 yr ago · Founded 2022
We Can Help You get to a Minimum Viable Product Fast When You Use Our Company. Contact Us!
KinexioVenture round · 2 yr ago · Founded 2012 · 51-200 employees
Mallcomm and MyTAG have merged to become Kinexio; the enterprise property management platform.
ProteinQureVenture round $1.8M · 5 mo ago · Founded 2017 · 51-200 employees · 1 role
ProteinQure is a Toronto biotechnology company founded in 2017 that designs peptide therapeutics computationally. Its platform combines…

Financials

Total raised
$4M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2026 $4M Details

People

Francis Herbert
Executive Officer, Director
Rajendra Singh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

News

Blog 30 days ago
Introducing Peptaris
Why we started a company to unlock the full therapeutic potential of peptides, and what we are building in Philadelphia.
Read more
Report
News University of Pennsylvania - Office of the Chief Innovation Officer
Penn's StartUP Fund Announces its First Investments
Newly launched $10M fund makes early-stage investments in Penn spinout companies.
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia United States
HQ
Lilly Gateway Labs2300 Market Street
10-50 est. staff
2300 Market Street, Philadelphia, 19103
company site